This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
3 Nov 2011

FDA Approves Felodipine Extended-release Tablets USP

FDA approves Endo Felodipine Extended-release Tablets USP, which are the generic version of AstraZeneca's Plendil Extended-release Tablets.

US-based specialty healthcare solutions company Endo Pharmaceuticals announced Wednesday that the FDA has approved Felodipine Extended-release Tablets USP, 2.5mg, 5mg and 10mg. 

 

Qualitest Pharmaceuticals, the generic business unit of Endo Pharmaceuticals, will manufacture and distribute the Felodipine Extended-release Tablets.

 

Felodipine Extended-release Tablets USP are the generic version of AstraZeneca's Plendil Extended-release Tablets.

 

The total sales for Felodipine in the U.S. for the 12 months ended June 30, 2011 were approximately $84 million, according to IMS Health.

Related News